Joseph L. Goldstein, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,000 shares at $617.18 ($617K) on 2020-08-21, disclosed to the SEC on 2020-08-24.
Seasonal sale ($617k) by Director — this insider has traded REGN in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2022-04-01 | $1.7M | — | Filing → |
| REGN | SELL | 2021-09-13 | $1.6M | — | Filing → |
| REGN | SELL | 2021-06-08 | $1.0M | — | Filing → |